We are live on ! Find out more
Bain Capital Investors

Bain Capital Investors Portfolio holdings

AUM $4.82B Turnover 12.5%
1-Year Est. Return 35.43%
This Fund
S&P 500
This Quarter Est. Return
+25.83%
1 Year Est. Return
+35.43%
3 Year Est. Return
+91.12%
5 Year Est. Return
+78.55%
10 Year Est. Return
+1,013.83%
AUM
$4.82B
AUM Growth
+$1.55B
Cap. Flow
+$577M
Cap. Flow %
11.98%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
–
Closed
–
Avg Time Held
3.1 years
Top 10 Avg Time Held
3.1 years
Top 20 Avg Time Held
3.1 years

Top Buys

Rank Stock Value
1
KLRA icon
Kailera Therapeutics
KLRA
+$577M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 62.9%
2 Consumer Discretionary 31.33%
3 Technology 5.67%
4 Communication Services 0.1%
5 Miscellaneous 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BOBS icon
1
Bobs Discount Furniture
BOBS
$2.68B
$1.51B 31.33%
95,370,751
– –
2026 Q1
1 quarter
SGRY icon
2
Surgery Partners
SGRY
$3.53B
$839M 17.42%
49,946,972
– –
2017 Q3
35 quarters
AVAH icon
3
Aveanna Healthcare
AVAH
$2.51B
$699M 14.52%
81,600,880
– –
2021 Q2
20 quarters
KMTS icon
4
Kestra Medical Technologies
KMTS
$1.71B
$640M 13.3%
25,172,338
– –
2025 Q1
5 quarters
KLRA icon
5
Kailera Therapeutics
KLRA
$1.72B
$578M 12.01%
+26,255,581
New +$577M
2026 Q2
0 quarters
NTNX icon
6
Nutanix
NTNX
$16.5B
$273M 5.67%
5,355,285
– –
2024 Q3
7 quarters
WAY icon
7
Waystar Holding Corp
WAY
$5.39B
$272M 5.65%
13,243,539
– –
2024 Q2
8 quarters
ADV icon
8
Advantage Solutions
ADV
$390M
$5M 0.1%
115,600
– –
2020 Q4
22 quarters

Similar funds

Bain Capital Investors's Q2 2026 Portfolio in Review

As of Q2 2026, Bain Capital Investors held 8 positions worth $4.82B, up 47% from $3.27B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Bain Capital Investors deployed $577M of net new capital in Q2 2026, opening 1 new position. Its largest new stake was Kailera Therapeutics: 26,255,581 shares worth $578M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 59% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bain Capital Investors's largest Q2 2026 buy was Kailera Therapeutics: 26,255,581 shares worth $578M.
  • Bain Capital Investors's ten largest holdings make up 100% of its $4.82B portfolio in Q2 2026.
  • Bain Capital Investors opened 1 new position and closed 0 in Q2 2026.
  • Bain Capital Investors's portfolio value rose 47% quarter-over-quarter to $4.82B.

Based on Bain Capital Investors's 13F filing for Q2 2026, filed 14 Aug 2026.